Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
SCHMIDT ERIC THOMAS
Chief Financial Officer at Allogene Therapeutics. Filing since 16 Mar 2020.
CIK 0001754403
Company
Date
Role
Action
Shares
Amount
Of holding
ALLO
Allogene Therapeutics, Inc.
15 Mar 2022
Chief Financial Officer
Sold, plan not stated
11,469
$87.55K
10.2%
ALLO
Allogene Therapeutics, Inc.
15 Mar 2021
Chief Financial Officer
Sold, plan not stated
8,053
$307.89K
10.2%
ALLO
Allogene Therapeutics, Inc.
15 Jan 2021
Chief Financial Officer
Sold, plan not stated
15,000
$483.86K
1.3%
ALLO
Allogene Therapeutics, Inc.
14 Jan 2021
Chief Financial Officer
Sold, plan not stated
15,000
$461.61K
1.3%
ALLO
Allogene Therapeutics, Inc.
16 Nov 2020
Chief Financial Officer
Sold, plan not stated
15,000
$493.15K
1.3%
ALLO
Allogene Therapeutics, Inc.
15 Oct 2020
Chief Financial Officer
Sold, plan not stated
15,000
$607.39K
1.2%
ALLO
Allogene Therapeutics, Inc.
21 Sep 2020
Chief Financial Officer
Sold, plan not stated
15,000
$529.54K
1.2%
ALLO
Allogene Therapeutics, Inc.
16 Mar 2020
Chief Financial Officer
Sold, plan not stated
5,450
$107.51K
10.3%
8 decisions on file.
